Corbus Pharmaceuticals Holdings Net Tangible Assets

Corbus Pharmaceuticals Holdings (CRBP) currently reports a net tangible assets of $100M as of June 2026. That compares with $110M in the prior-year period — down 7.9% year over year. Use the charts on this page to explore Corbus Pharmaceuticals Holdings's net tangible assets history and peer comparisons.

Corbus Pharmaceuticals Holdings's net tangible assets decreased from $110M to $100M — a 7.9% year-over-year decrease (period ending June 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Corbus Pharmaceuticals Holdings reported $100M in net tangible assets as of June 2026. That compares with $110M in the prior-year period — down 7.9% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current net tangible assets of $100M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Corbus Pharmaceuticals Holdings, and consider following CRBP for alerts when major investors trade the stock.

Corbus Pharmaceuticals Holdings is classified in the Healthcare sector. On net tangible assets, it currently shows $100M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing CRBP with unrelated industries.